HscA, a specialized bacterial hsp70-class chaperone, interacts with the iron-sulfur cluster assembly protein IscU by recognizing a conserved LPPVK sequence motif at positions 99-103. We have used a site-directed fluorescence labeling and quenching strategy to determine whether HscA binds to IscU in a preferred orientation. HscA was selectively labeled on opposite sides of the substrate binding domain with the fluorescent probe bimane, and the ability of LPPVK-containing peptides having tryptophan at the N-or C-terminus to quench bimane fluorescence was measured. Quenching was highly dependent on the position of tryptophan in the peptide and the location of bimane on HscA implying a strong directional preference for peptide binding. Similar experiments showed that full length IscU binds in the same orientation as IscU-derived peptides and that binding orientation is unaffected by the co-chaperone HscB. The preferred orientation of the HscA-IscU complex is the reverse of that previously described for peptide complexes of E. coli DnaK and rat Hsc70 substrate binding domain fragments establishing that hsp70 isoforms can bind peptide/polypeptide substrates in different orientations.
INTRODUCTION
min -1 . Correction and integration of emission spectra were carried out using Excel (Microsoft), and curve-fitting was performed using KaleidaGraph (Synergy Software).
RESULTS
Experimental rationale-We used site-directed labeling with the fluorescent probe bimane and quenching by tryptophan containing peptides (see Fig. 1 ) to determine the orientation of substrates bound to HscA. This approach takes advantage of the short-range quenching of bimane fluorescence by tryptophan, a process that involves collisional contact between the bimane excited state and the indole ring of tryptophan (22,23). Bimane fluorescence displays some variation with environmental parameters (19, 24) , but its efficient quenching by tryptophan can provide a measure of short-range interactions in proteins (25). The substrate binding domain of HscA was selectively labeled with monobromobimane, and the ability of IscU-derived peptides having tryptophan at the N-or C-terminus (W-97 and W-105) to quench bimane fluorescence was measured. Mutant forms of the full-length IscU protein having tryptophan in the corresponding positions (L97W and H105W) were also tested for their ability to quench bimane-labeled HscA.
We have recently constructed models of the substrate binding domain of HscA bound to the IscU peptide ELPPVKI (13) based on the crystal structure of the DnaK substrate binding domain complexed to the peptide NRLLLTG (14) . The β-sandwich subdomain of HscA exhibits 50% sequence identity to that of DnaK suggesting that the peptide binding regions are likely to have similar structures. (14) . We have designated the back-to-front orientation shown as the "reverse" direction relative to the "forward" direction originally observed for the DnaK-NRLLLTG peptide complex. To identify positions for bimane labeling we inspected the model for surface residues close to the position at which the peptide exits the binding cleft. Gln 421 and Asp 422 , located just below the cleft on the front side, and Ala 455 , located just below the cleft on the back side, appeared to provide labeling sites that might allow bimane to selectively interact with N-or C-terminal residues of bound peptides.
Cysteine mutants of HscA-Cysteine residues were introduced into HscA at positions 421, 422 or 455 to allow bimane labeling. To ensure specific labeling at these sites the endogenous cysteine residues at positions 315 and 448 of HscA were first changed to serine by mutagenesis. This resulting double mutant, HscA(C315S/C448S), was then used as a template to generate three triple mutants, designated HscA(Q421C), HscA(D422C) and HscA(A455C), containing unique cysteine labeling sites. Each of the mutants behaved similarly to wild-type HscA during purification suggesting that no gross structural changes resulted from the amino acid replacements.
To assess whether the different cysteine substitutions affected functional properties of the proteins, each mutant was assayed for ATPase and chaperone activity as well as for interactions with peptides and IscU. Table 1 While it is possible that the failure of specific peptides to quench fluorescence could result from restricted positioning of the tryptophan residue, the agreement of the findings with front-and back-labeled HscA-bimane derivatives argues in favor of single preferred orientation.
The binding affinity of the peptides for the HscA-bimane derivatives was analyzed by integration of the emission curves in Fig. 3 at each concentration of added peptide (Fig. 4) . (Table 1) consistent with their interaction with the substrate binding domain in a manner similar to wild-type IscU.
Fluorescence experiments carried out using bimane-labeled HscA(D422C) showed weak effects of IscU(L97W) and IscU(H105W) on the fluorescence of this derivative (see Supplemental Figure 2 ). Addition of IscU(H105W) led to a small degree of quenching (≅7%), whereas the IscU(L97W) mutant gave a small increase in fluorescence (≅8%). The fact that quenching is observed only with IscU (H105W) is consistent with the reverse orientation deduced from the peptide binding experiments described above. However, the small effects observed make it difficult to determine binding affinities and to interpret the results using this derivative with Additions: peptides, 300 µm; IscU, IscU(l97W) and IscU H105W, 100 µM; HscB, 50 µM. The concentrations used are near saturating levels (cf. Fig. 4 and 7) , and the specific activities reported (mol ATP hydrolyzed / mol HscA / min) therefore reflect approximate maximal turnover numbers. Side chains of HscA residues selected for cysteine mutagenesis and bimane labeling are shown in red. The model shown, with the peptide in the reverse orientation from that observed for the DnaK-NRLLLTG complex, is derived from Reference 13. The structural representations were generated using VMD (48) . 
